 Veracyte, Inc. NASDAQ:VCYT Q2 2022 Earnings Conference Call August 2, 2022 4:30 PM ET Company Participants Shayla Gorman - Director of Investor Relations Marc Stapley - Chief Executive Officer Rebecca Chambers - Chief Financial Officer Tina Nova - President of CLIA Business Giulia Kennedy - Global Chief Scientific Officer and Chief Medical Officer Conference Call Participants Brian Weinstein - William Blair Puneet Souda - SVB Securities Matt Sykes - Goldman Sachs Tejas Savant - Morgan Stanley Andrew Cooper - Raymond James Mike Matson - Needham Company Mason Carrico - Stephens Paul Knight - KeyBanc Operator Good day, and thank you for standing by. Welcome to the Veracyte Second Quarter 2022 Financial Results Conference Call Operator Instructions. 